VIP



VIP

H1HH1S2SS2D3DD3A4AA4V5VV5F6FF6T7TT7D8DD8N9NN9Y10YY10T11TT11R12RR12L13LL13R14RR14K15KK15Q16QQ16M17MM17A18AA18V19VV19K20KK20K21KK21Y22YY22L23LL23N24NN24S25SS25I26II26L27LL27N28NN28

SMILES None
InChIKey VBUWHHLIZKOSMS-UHFFFAOYSA-N
Sequence HSDAVFTDNYTRLRKQMAVKKYLNSILN

Chemical Properties

Hydrogen bond acceptors None
Hydrogen bond donors None
Rotatable bonds None
Molecular weight (Da)

Database connections

Ligand site mutations VPAC1 VPAC2


Bioactivities

VIP

H1HH1S2SS2D3DD3A4AA4V5VV5F6FF6T7TT7D8DD8N9NN9Y10YY10T11TT11R12RR12L13LL13R14RR14K15KK15Q16QQ16M17MM17A18AA18V19VV19K20KK20K21KK21Y22YY22L23LL23N24NN24S25SS25I26II26L27LL27N28NN28

Drug properties

Molecular type Peptide
Physiological/Surrogate Endogenous
Approved drug No

Distribution across phases (no. indications)

Phase I 0
Phase II 0
Phase III 0
Phase IV 0

Database connections

Ligand site mutations VPAC1 VPAC2


Compound is not listed as a drug.